Biography

Adam Schechter became chief executive officer of Labcorp (NYSE: LH) in November 2019 and chairman in May 2020. Previously, Schechter was named lead independent director in January 2019 after serving on the board since 2013.

Under Schechter’s leadership, Labcorp, a leading global life sciences company with more than 80,000 employees, harnesses science, innovation and technology to improve health and improve lives. Through its strong diagnostics and drug development capabilities, vast health data and insights, and extensive global laboratory network, the company advances healthcare across all major clinical and therapeutic areas, including oncology, Alzheimer’s, autoimmune and liver diseases, and more.

Labcorp is helping customers bring innovative, life-changing treatments and vaccines to market by leveraging its combined expertise in drug development and diagnostics. With these capabilities, Schechter, with his colleagues at Labcorp, created a model for addressing emerging health crises with their response to the COVID-19 pandemic and the Monkeypox virus.

Schechter joined Labcorp after a long and distinguished career at Merck, where he served as executive vice president and president of global human health and was a member of the executive committee. At Merck, among other accomplishments, Schechter focused on ensuring that Merck’s medicines and vaccines were available to people around the world, led a large global organization across the spectrum of commercial operations, transformed Merck’s commercial model, and led the integration of Merck and Schering-Plough.

He is the vice chair of the Board of Directors for the American Clinical Laboratory Association (ACLA), a board member for Water.org, and serves as an independent director on the board of DaVita, Inc. Schechter is chair of the Corporate Advisory Council for the National Alliance for Hispanic Health, a longtime leader and advocate on Hispanic issues and an Executive Advisor to its Healthy Americas Foundation.

Schechter holds a Bachelor of Arts in Biology from La Salle University and was awarded an honorary Doctor of Humane Letters degree from the university in 2021.